News

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2024.03.12
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2023.11.13
Genomtec received positive evaluation of Grant in Oncology Diagnostics from the Polish Agency for Enterprise Development (PARP) and the European Funds for a Modern Economy program

Archive

2021.06.24

Genetic tests Genomtec SARS-CoV-2 Duo Kit (Cat. no.: GA00B) and Direct-RT-LAMP Kit (Cat. no.: GA00C) detect multiple virus lineages

RT-LAMP Duo and Direct Kits’ reliability in recognition of identified SARS-CoV-2 significant variants, among them the Breton that has the ...
Read
2021.06.23

Jarosław Oleszczuk changes his scope of involvement in Genomtec transiting from Management Board to Supervisory Board

The company announced in the draft resolution of the Extraordinary General Meeting of Shareholders convened on July 20 this year, with the ...
Read
2021.05.31

Genomtec strengthens the management board – Charudutt Shah joins the company

Genomtec SA announced that Charudutt Shah is joining the board. The newly appointed member of the Genomtec board is a senior executive with many ...
Read
2021.05.27

Genomtec expands patient group in the additional comparative study of its COVID-19 test directly from saliva

Genomtec S.A. will conduct additional comparative study of its test detecting SARS-CoV-2 directly from saliva sample utilizing the Direct-RT-LAMP ...
Read
2021.05.17

Genomtec launches the world’s first genetic diagnostic test for the detection of SARS-CoV-2 directly from a saliva sample

Genomtec S.A., listed on the NewConnect market at Warsaw Stock Exchange, a company developing medical technology applicable in segment of ...
Read
2021.05.10

Genomtec receives the third patent based on the LAMP technique

Company has been granted a patent protection from the Patent Office of the Republic of Poland for a set of primers amplifying Borrelia ...
Read

Archive